Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation

Area of Science:

• Immunology
• Hematology
• Transplantation Science

Background:

• Autoimmune manifestations post-allogeneic hematopoietic stem cell transplantation (AHSCT) are uncommon and complex.
• These conditions differ from graft-versus-host disease (GvHD), often targeting the hematopoietic system (autoimmune cytopenias) or other organs.

Purpose of the Study:

• To review the incidence, risk factors, pathophysiology, treatment, and prognosis of autoimmune conditions in children following AHSCT.
• To differentiate these autoimmune events from GvHD and explore their alloimmune basis.

Main Methods:

• Review of existing literature on autoimmune manifestations after AHSCT in pediatric populations.
• Analysis of case studies and clinical data to understand the distinct characteristics of these conditions.

Main Results:

• Autoimmune cytopenias (hemolytic anemia, thrombocytopenia, neutropenia) are donor-vs-donor reactions.
• Non-hematologic autoimmune conditions affect organs like the thyroid, nervous system, skin, liver, and kidneys, potentially due to alloimmunity.
• These conditions are primarily antibody-mediated.

Conclusions:

• Autoimmune manifestations post-AHSCT require careful diagnosis and management, distinct from GvHD.
• Understanding the alloimmune mechanisms is crucial for improving outcomes in pediatric transplant recipients.